Cardiomyopathy, Dilated
|
0.510 |
Biomarker
|
group |
CTD_human |
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
|
11986409 |
2002 |
Asthma
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Insulin Resistance
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.
|
19034036 |
2008 |
Obesity
|
0.500 |
Biomarker
|
disease |
CTD_human |
beta2-adrenergic receptor polymorphisms and salbutamol-stimulated energy expenditure.
|
15687340 |
2005 |
Malignant neoplasm of prostate
|
0.350 |
Biomarker
|
disease |
CTD_human |
Interestingly, beta(2)-AR mRNA was strongly down-regulated by androgen ablation therapy of prostate cancer patients.
|
18454446 |
2008 |
Malignant neoplasm of stomach
|
0.340 |
Biomarker
|
disease |
CTD_human |
Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells.
|
17003101 |
2007 |
Lung diseases
|
0.330 |
Biomarker
|
group |
CTD_human |
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
|
11436944 |
2001 |
Myocardial Ischemia
|
0.330 |
Biomarker
|
disease |
CTD_human |
Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy.
|
9554809 |
1998 |
Cirrhosis
|
0.330 |
Biomarker
|
disease |
CTD_human |
Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
|
25193472 |
2014 |
Autistic Disorder
|
0.310 |
Biomarker
|
disease |
CTD_human |
The objective of this study was to determine whether alleles in ADRB2 are associated with diagnosis of autism in the Autism Genetic Resource Exchange (AGRE) population.
|
17199132 |
2007 |
Hyperlipidemia
|
0.310 |
Biomarker
|
disease |
CTD_human |
beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.
|
16027735 |
2005 |
Hypokalemia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.
|
1848636 |
1991 |
Hypokalemia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
The influence of the AA 16 beta 2-adrenoceptor polymorphism on systemic and airway responses in asthma.
|
17292646 |
2008 |
Hypokalemia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Beta-2-adrenoceptor-mediated hypokalemia and its abolishment by oxprenolol.
|
2826064 |
1987 |
Prostatic Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
|
18454446 |
2008 |
Cardiomyopathies
|
0.310 |
Biomarker
|
group |
CTD_human |
Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
|
25193472 |
2014 |
AIDS Dementia Complex
|
0.300 |
Biomarker
|
disease |
CTD_human |
β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization.
|
27400929 |
2016 |
Fibrosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
|
25193472 |
2014 |
HIV Infections
|
0.300 |
Biomarker
|
group |
CTD_human |
β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization.
|
27400929 |
2016 |
nervous system disorder
|
0.300 |
Biomarker
|
group |
CTD_human |
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.
|
21245421 |
2011 |
Cardiomyopathies, Primary
|
0.300 |
Biomarker
|
group |
CTD_human |
Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
|
25193472 |
2014 |
Myocardial Diseases, Secondary
|
0.300 |
Biomarker
|
group |
CTD_human |
Disruption of type 5 adenylyl cyclase prevents β-adrenergic receptor cardiomyopathy: a novel approach to β-adrenergic receptor blockade.
|
25193472 |
2014 |
Stomach Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells.
|
17003101 |
2007 |
Tremor
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
|
9151294 |
1997 |
Tremor
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
|
7902979 |
1993 |